412 related articles for article (PubMed ID: 22845427)
41. Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial.
Ho PM; Lambert-Kerzner A; Carey EP; Fahdi IE; Bryson CL; Melnyk SD; Bosworth HB; Radcliff T; Davis R; Mun H; Weaver J; Barnett C; Barón A; Del Giacco EJ
JAMA Intern Med; 2014 Feb; 174(2):186-93. PubMed ID: 24247275
[TBL] [Abstract][Full Text] [Related]
42. The expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes.
Goodman SG; Huang W; Yan AT; Budaj A; Kennelly BM; Gore JM; Fox KA; Goldberg RJ; Anderson FA;
Am Heart J; 2009 Aug; 158(2):193-201.e1-5. PubMed ID: 19619694
[TBL] [Abstract][Full Text] [Related]
43. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
44. Differences in the use of guideline-recommended therapies among 14 European countries in patients with acute coronary syndromes undergoing PCI.
Zeymer U; James S; Berkenboom G; Mohacsi A; Iñiguez A; Coufal Z; Sartral M; Paget MA; Norrbacka K; Ferrieres J; Bakhai A;
Eur J Prev Cardiol; 2013 Apr; 20(2):218-28. PubMed ID: 22345684
[TBL] [Abstract][Full Text] [Related]
45. [Evaluation of hospitalization period and five-year follow-up of patients admitted with acute coronary syndrome following coronary artery bypass graft surgery].
Can LH; Kayıkçıoğlu M; Yavuzgil O; Kültürsay H; Soydan I
Turk Kardiyol Dern Ars; 2010 Sep; 38(6):387-92. PubMed ID: 21200116
[TBL] [Abstract][Full Text] [Related]
46. [Chilean results of the international registry of risk factors and treatment of unstable angina and non ST elevation myocardial infarction: ACCORD (ACute CORonary syndrome Descriptive study)].
Stockins B; Albornoz F; Martínez D; Campos P; Gajardo J; Lamich R; Manríquez L; Pérez V; Rojo P; Sepúlveda P; Pumarino MG; Corbalán R
Rev Med Chil; 2011 Jan; 139(1):19-26. PubMed ID: 21526313
[TBL] [Abstract][Full Text] [Related]
47. Age-related differences in the use of guideline-recommended medical and interventional therapies for acute coronary syndromes: a cohort study.
Schoenenberger AW; Radovanovic D; Stauffer JC; Windecker S; Urban P; Eberli FR; Stuck AE; Gutzwiller F; Erne P;
J Am Geriatr Soc; 2008 Mar; 56(3):510-6. PubMed ID: 18179499
[TBL] [Abstract][Full Text] [Related]
48. Use of evidence-based therapy for the prevention of cardiovascular events among older people.
Castelino RL; Chen TF; Guddattu V; Bajorek BV
Eval Health Prof; 2010 Sep; 33(3):276-301. PubMed ID: 20801973
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of proper prescribing of cardiac medications at hospital discharge for patients with acute coronary syndromes (ACS) in two Lebanese hospitals.
Sheikh-Taha M; Hijazi Z
Springerplus; 2014; 3():159. PubMed ID: 24790814
[TBL] [Abstract][Full Text] [Related]
50. Use of renin-angiotensin system blockers in acute coronary syndromes: findings from Get With the Guidelines-Coronary Artery Disease Program.
Bainey KR; Armstrong PW; Fonarow GC; Cannon CP; Hernandez AF; Peterson ED; Peacock WF; Laskey WK; Zhao X; Schwamm LH; Bhatt DL
Circ Cardiovasc Qual Outcomes; 2014 Mar; 7(2):227-35. PubMed ID: 24569634
[TBL] [Abstract][Full Text] [Related]
51. Optimal medical therapy for secondary prevention after an acute coronary syndrome: 18-month follow-up results at a tertiary teaching hospital in South Korea.
Byeon HJ; Yang YM; Choi EJ
Ther Clin Risk Manag; 2016; 12():167-75. PubMed ID: 26929629
[TBL] [Abstract][Full Text] [Related]
52. Tackling inequalities: are secondary prevention therapies for reducing post-infarction mortality used without disparities?
Buja A; Boemo DG; Furlan P; Bertoncello C; Casale P; Baldovin T; Marcolongo A; Baldo V
Eur J Prev Cardiol; 2014 Feb; 21(2):222-30. PubMed ID: 22997352
[TBL] [Abstract][Full Text] [Related]
53. Impact of evidence-based cardiac medication on short- and long-term mortality in 7,567 acute coronary syndrome patients in the Gulf RACE-II registry.
Al-Zakwani I; Sulaiman K; Al Za'abi M; Panduranga P; Al-Habib K; Asaad N; Al Motarreb A; Hersi A; Al Faleh H; Al Saif S; Almahmeed W; Amin H; Alsheikh-Ali A; Al Lawati J; Al Suwaidi J
Int J Clin Pharmacol Ther; 2012 Jun; 50(6):418-25. PubMed ID: 22541748
[TBL] [Abstract][Full Text] [Related]
54. Early treatment for non-ST-segment elevation acute coronary syndrome is associated with appropriate discharge care.
Fermann GJ; Raja AS; Peterson ED; Roe MT; Hoekstra JW; Milford-Beland S; Diercks DB; Pollack CV; Peacock WF; Summers R; Ohman EM; Gibler WB
Clin Cardiol; 2009 Sep; 32(9):519-25. PubMed ID: 19743495
[TBL] [Abstract][Full Text] [Related]
55. Weekend/holiday versus weekday hospital discharge and guideline adherence (from the American Heart Association's Get with the Guidelines--Coronary Artery Disease database).
Tickoo S; Fonarow GC; Hernandez AF; Liang L; Cannon CP
Am J Cardiol; 2008 Sep; 102(6):663-7. PubMed ID: 18773984
[TBL] [Abstract][Full Text] [Related]
56. An analysis of the Association of Society of Chest Pain Centers Accreditation to American College of Cardiology/American Heart Association non-ST-segment elevation myocardial infarction guideline adherence.
Chandra A; Glickman SW; Ou FS; Peacock WF; McCord JK; Cairns CB; Peterson ED; Ohman EM; Gibler WB; Roe MT
Ann Emerg Med; 2009 Jul; 54(1):17-25. PubMed ID: 19282062
[TBL] [Abstract][Full Text] [Related]
57. Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry.
Lim MJ; Spencer FA; Gore JM; Dabbous OH; Agnelli G; Kline-Rogers EM; Dibenedetto D; Eagle KA; Mehta RH;
Eur Heart J; 2005 Jun; 26(11):1063-9. PubMed ID: 15716281
[TBL] [Abstract][Full Text] [Related]
58. Improved adherence to practice guidelines yields better outcome in high-risk patients with acute coronary syndrome without ST elevation: findings from nationwide FINACS studies.
Vikman S; Airaksinen KE; Tierala I; Peuhkurinen K; Majamaa-Voltti K; Niemelä M; Tuunanen H; Nieminen MS; Niemelä K
J Intern Med; 2004 Oct; 256(4):316-23. PubMed ID: 15367174
[TBL] [Abstract][Full Text] [Related]
59. Angiotensin receptor blockers vs. angiotensin converting enzyme inhibitors and acute coronary syndrome outcomes in elderly patients: a population-based cohort study (UMPIRE study results).
Verma S; Mamdani MM; Al-Omran M; Melo M; Rouleau JL
J Am Soc Hypertens; 2007; 1(4):286-94. PubMed ID: 20409860
[TBL] [Abstract][Full Text] [Related]
60. Prevalence and correlates of non-optimal secondary medical prevention in patients with stable coronary artery disease.
Meurice T; Tricot O; Lemesle G; Deneve M; Lejeune P; Biausque F; Cordier C; Savoye C; Hennebert O; Taghipour K; Sivery B; Pruvost P; Alaoui M; Carpentier L; Segrestin B; Lamblin N; Bauters C
Arch Cardiovasc Dis; 2015; 108(6-7):340-6. PubMed ID: 25858539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
